World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
93
Citations
38109
World Ranking
10761
National Ranking
5535

Overview

Philippe Armand is affiliated with Harvard University in the United States and has contributed extensively to the field of medicine, with particular focus on oncology, pathology, immunology, genetics, and neurology. Their work is documented through numerous publications that emphasize lymphoma diagnosis and treatment, cancer immunotherapy, CAR-T cell therapy research, and chronic lymphocytic leukemia research among other topics.

Armand's main fields of study include:

  • Medicine

The subfields they have contributed to encompass:

  • Oncology
  • Pathology and Forensic Medicine
  • Genetics
  • Immunology
  • Neurology

Major research topics covered in their publications include:

  • Lymphoma Diagnosis and Treatment
  • CAR-T cell therapy research
  • Cancer Immunotherapy and Biomarkers
  • Chronic Lymphocytic Leukemia Research
  • CNS Lymphoma Diagnosis and Treatment
  • Immune Cell Function and Interaction
  • Viral-associated cancers and disorders

Recent papers authored or co-authored by Armand feature notable work such as:

  • "NCCN Guidelines Insights: Management of Immunotherapy-Related Toxicities, Version 1.2020" (2020), published in Journal of the National Comprehensive Cancer Network
  • "Management of Immunotherapy-Related Toxicities, Version 1.2022, NCCN Clinical Practice Guidelines in Oncology" (2022), published in Journal of the National Comprehensive Cancer Network
  • "Axicabtagene Ciloleucel in the Non-Trial Setting: Outcomes and Correlates of Response, Resistance, and Toxicity" (2020), published in Journal of Clinical Oncology
  • "Hodgkin Lymphoma, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology" (2020), published in Journal of the National Comprehensive Cancer Network
  • "Atorvastatin for Anthracycline-Associated Cardiac Dysfunction" (2023), published in JAMA

Frequent collaborators throughout these research efforts include:

  • Caron A. Jacobson
  • Reid W. Merryman
  • Robert Redd
  • Jennifer L. Crombie
  • Alex F. Herrera

Philippe Armand's publications appear predominantly in these venues:

  • Blood
  • Blood Advances
  • Hematological Oncology
  • Journal of Clinical Oncology
  • Leukemia & lymphoma/Leukemia and lymphoma

Best Publications

  • PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma

    Stephen M. Ansell;Alexander M. Lesokhin;Alexander M. Lesokhin;Ivan Borrello;Ahmad Halwani

  • Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease

    John Koreth;Ken Ichi Matsuoka;Haesook T. Kim;Sean M. McDonough

  • Nivolumab in patients with relapsed or refractory hematologic malignancy: Preliminary results of a phase ib study

    Alexander M. Lesokhin;Alexander M. Lesokhin;Stephen M. Ansell;Philippe Armand;Emma C. Scott

  • Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphoma.

    Robert Chen;Pier Luigi Zinzani;Michelle A. Fanale;Philippe Armand

  • Nivolumab for classical Hodgkin's lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: a multicentre, multicohort, single-arm phase 2 trial

    Anas Younes;Armando Santoro;Margaret Shipp;Pier Luigi Zinzani

  • Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation

    Philippe Armand;Haesook T. Kim;Brent R. Logan;Zhiwei Wang

  • Nivolumab for Relapsed/Refractory Classic Hodgkin Lymphoma After Failure of Autologous Hematopoietic Cell Transplantation: Extended Follow-Up of the Multicohort Single-Arm Phase II CheckMate 205 Trial.

    Philippe Armand;Andreas Engert;Anas Younes;Michelle A Fanale

  • PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome

    Margaretha G.M. Roemer;Ranjana H. Advani;Azra H. Ligon;Yasodha Natkunam

  • Programmed Death-1 Blockade With Pembrolizumab in Patients With Classical Hodgkin Lymphoma After Brentuximab Vedotin Failure

    Philippe Armand;Margaret A. Shipp;Vincent Ribrag;Jean Marie Michot

  • Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia

    Stefan O. Ciurea;Mei Jie Zhang;Andrea A. Bacigalupo;Asad Bashey

  • Ipilimumab for Patients with Relapse after Allogeneic Transplantation

    Matthew S. Davids;Haesook T. Kim;Pavan Bachireddy;Caitlin Costello

  • Management of Immunotherapy-Related Toxicities, Version 1.2019.

    John A. Thompson;Bryan J. Schneider;Julie Brahmer;Stephanie Andrews

  • Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an International Phase II Trial

    Philippe Armand;Arnon Nagler;Edie A. Weller;Steven M. Devine

  • Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation

    Philippe Armand;Haesook T. Kim;Corey S. Cutler;Vincent T. Ho

  • Low-Dose Interleukin-2 Therapy Restores Regulatory T Cell Homeostasis in Patients with Chronic Graft-Versus-Host Disease

    Ken-ichi Matsuoka;John Koreth;Haesook T. Kim;O. Gregory Bascug

  • Antiretroviral-Free HIV-1 Remission and Viral Rebound After Allogeneic Stem Cell Transplantation: Report of 2 Cases

    Timothy J. Henrich;Emily Hanhauser;Francisco M. Marty;Michael N. Sirignano

  • PD-1 Inhibitor–Related Pneumonitis in Advanced Cancer Patients: Radiographic Patterns and Clinical Course

    Mizuki Nishino;Nikhil H. Ramaiya;Mark M. Awad;Lynette M. Sholl

  • Refinement of the Lugano Classification lymphoma response criteria in the era of immunomodulatory therapy.

    Bruce D. Cheson;Stephen Ansell;Larry Schwartz;Leo I. Gordon

  • Somatic Mutations Predict Poor Outcome in Patients With Myelodysplastic Syndrome After Hematopoietic Stem-Cell Transplantation

    Rafael Bejar;Kristen E. Stevenson;Bennett Caughey;R. Coleman Lindsley

  • PD-1 blockade with nivolumab in relapsed/refractory primary central nervous system and testicular lymphoma

    Lakshmi Nayak;Lakshmi Nayak;Fabio M. Iwamoto;Ann LaCasce;Ann LaCasce;Srinivasan Mukundan;Srinivasan Mukundan

Frequent Co-Authors

Robert J. Soiffer
Robert J. Soiffer Harvard University
Joseph H. Antin
Joseph H. Antin Dana-Farber Cancer Institute
Vincent T. Ho
Vincent T. Ho Harvard University
Corey Cutler
Corey Cutler Harvard University
Edwin P. Alyea
Edwin P. Alyea Harvard University
John Koreth
John Koreth Harvard University
Haesook T. Kim
Haesook T. Kim Harvard University
Jerome Ritz
Jerome Ritz Harvard University
Scott J. Rodig
Scott J. Rodig Harvard University
Margaret A. Shipp
Margaret A. Shipp Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online healthcare degrees opens diverse routes for advancing your career. If you’re seeking flexibility and credibility, it’s important to consider which online healthcare degree programs are recognized for their accreditation by cahme? Accreditation ensures your qualification is respected by employers and licensing bodies.

For registered nurses looking to advance, you might wonder, does rn to bsn require clinicals? Many top RN to BSN programs now offer non-clinical pathways, providing a convenient option for working professionals who need flexibility.

Nurses aiming for the highest level of clinical practice may be interested in the shortest msn to dnp program options available online. These accelerated tracks can help you reach your Doctor of Nursing Practice with less time away from work.

If you are balancing work and study, discovering the easiest dnp programs may help you find the right fit. Streamlined curricula can make this advanced degree more accessible, supporting your journey in healthcare leadership.

Best Scientists Citing Philippe Armand

Trending Scientists

Recently Published Articles